245 related articles for article (PubMed ID: 27911910)
1. Molecular Markers of Radiation Induced Attenuation in Intrahepatic Plasmodium falciparum Parasites.
Oakley MS; Verma N; Zheng H; Anantharaman V; Takeda K; Gao Y; Myers TG; Pham PT; Mahajan B; Kumar N; Sangweme D; Tripathi AK; Mlambo G; Aravind L; Kumar S
PLoS One; 2016; 11(12):e0166814. PubMed ID: 27911910
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated pre-erythrocytic malaria vaccines.
Keitany GJ; Vignali M; Wang R
Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
[TBL] [Abstract][Full Text] [Related]
3. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
4. Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW
Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models.
Shears MJ; Seilie AM; Kim Lee Sim B; Hoffman SL; Murphy SC
Malar J; 2020 Aug; 19(1):313. PubMed ID: 32867784
[TBL] [Abstract][Full Text] [Related]
7. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites.
van Schaijk BC; Ploemen IH; Annoura T; Vos MW; Foquet L; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Sajid M; Franetich JF; Lorthiois A; Leroux-Roels G; Meuleman P; Hermsen CC; Mazier D; Hoffman SL; Janse CJ; Khan SM; Sauerwein RW
Elife; 2014 Nov; 3():. PubMed ID: 25407681
[TBL] [Abstract][Full Text] [Related]
8. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
Epstein JE; Richie TL
Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
[TBL] [Abstract][Full Text] [Related]
9. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.
Goswami D; Patel H; Betz W; Armstrong J; Camargo N; Patil A; Chakravarty S; Murphy SC; Sim BKL; Vaughan AM; Hoffman SL; Kappe SH
EMBO Mol Med; 2024 Apr; 16(4):723-754. PubMed ID: 38514791
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced cellular and molecular alterations in asexual intraerythrocytic Plasmodium falciparum.
Oakley MS; Gerald N; Anantharaman V; Gao Y; Majam V; Mahajan B; Pham PT; Lotspeich-Cole L; Myers TG; McCutchan TF; Morris SL; Aravind L; Kumar S
J Infect Dis; 2013 Jan; 207(1):164-74. PubMed ID: 23100570
[TBL] [Abstract][Full Text] [Related]
11. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
[TBL] [Abstract][Full Text] [Related]
12. The Development of Whole Sporozoite Vaccines for
Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
Front Immunol; 2018; 9():2748. PubMed ID: 30619241
[TBL] [Abstract][Full Text] [Related]
13. Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.
Siau A; Silvie O; Franetich JF; Yalaoui S; Marinach C; Hannoun L; van Gemert GJ; Luty AJ; Bischoff E; David PH; Snounou G; Vaquero C; Froissard P; Mazier D
PLoS Pathog; 2008 Aug; 4(8):e1000121. PubMed ID: 18688281
[TBL] [Abstract][Full Text] [Related]
14. Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics.
Swearingen KE; Lindner SE; Shi L; Shears MJ; Harupa A; Hopp CS; Vaughan AM; Springer TA; Moritz RL; Kappe SH; Sinnis P
PLoS Pathog; 2016 Apr; 12(4):e1005606. PubMed ID: 27128092
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine.
Mo AX; McGugan G
Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395
[TBL] [Abstract][Full Text] [Related]
16. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
[TBL] [Abstract][Full Text] [Related]
17. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of
James ER; Matheny S; Overby J; Sim BKL; Eappen AG; Li T; Li ML; Richie TL; Chakravarty S; Gunasekera A; Murshedkar T; Billingsley PF; Hoffman SL
Front Immunol; 2022; 13():851028. PubMed ID: 35242146
[TBL] [Abstract][Full Text] [Related]
18. A replication-competent late liver stage-attenuated human malaria parasite.
Goswami D; Betz W; Locham NK; Parthiban C; Brager C; Schäfer C; Camargo N; Nguyen T; Kennedy SY; Murphy SC; Vaughan AM; Kappe SH
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484795
[TBL] [Abstract][Full Text] [Related]
19. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM
PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160
[TBL] [Abstract][Full Text] [Related]
20. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.
Kumar H; Frischknecht F; Mair GR; Gomes J
Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
